FDA approves new injection to treat hives
Note: this article is provided by ONU Healthwise Pharmacy.
There's a newly approved treatment for hives.
The US Food and Drug Administration (FDA) has approved Quzyttir (cetirizine) to treat acute urticaria (hives).
Available as an injection to be given into the vein (IV), this new medication is approved for adults and children 6 months of age and older.
Cetirizine injection is now an alternative treatment option to IV diphenhydramine (brand name Benadryl).
The approved dose is once every 24 hours as needed for acute hives.
This approval comes after cetirizine injection was shown to be effective in a clinical trial that included 262 adults with hives. Some patients received cetirizine injection, while others received diphenhydramine injection.
Common side effects may include headache, altered taste, feeling hot, indigestion and excessive sweating. This medication may cause drowsiness. Be cautious if driving or operating heavy machinery.
Speak with your health care provider if you have any questions about hives or the available treatments.
Stories Posted This Week
Saturday, April 26, 2025
- Kenneth Eugene Mast was head athletic coach for Bluffton College
- Eagle eye over Village Park
- Hillville Rd. barn fire on April 24
- Agenda for April 28 Bluffton Council meeting
- Cory-Rawson High School celebrates Community Day
- Bluffton Senior Center news for May 2025
- Weekend Doctor: The current situation with measles
Friday, April 25, 2025
Thursday, April 24, 2025
- Blanchard Valley Health Foundation welcomes Sapp as Chief Development Officer
- LEO Club invitation to 5K and 1-mile walk & stroll
- Memorial bench and tree planting at Village Arboretum
- Bluffton Beavers sports roundup, April 16-22
- Pirate baseball loss vs. Fort Jennings
- Alan Garmatter is new CNB Chief Credit Officer
- Parks & Recreation Committee meets April 25
- Bad Dreams: Health implications